Form 4 holding
Chief Operating Officer
CRISPR Therapeutics AG
- Security class
- Common Shares
- Shares / value
- 10,544
- Estimated value
- $434,729
- Report date
- 21 Mar 2025
- Price
- $41.23
- Ownership
- Direct
Julianne Bruno - Chief Operating Officer at CRISPR Therapeutics AG
Issuer-level insider activity
- Role
- Chief Operating Officer
- Issuer ticker
- CRSP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Julianne Bruno since 03 Aug 2025
Reported holdings for Julianne Bruno in CRISPR Therapeutics AG
Form 4 holding
Chief Operating Officer
CRISPR Therapeutics AG
- Security class
- Common Shares
- Shares / value
- 7,088
- Estimated value
- $292,238
- Report date
- 20 Mar 2025
- Price
- $41.23
- Ownership
- The Julianne Bruno 2022 GRAT
Form 4 holding
Chief Operating Officer
CRISPR Therapeutics AG
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 36,666
- Estimated value
- Report date
- 14 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Form 4 holding
Chief Operating Officer
CRISPR Therapeutics AG
- Security class
- Restricted Stock Units
- Shares / value
- 11,250
- Estimated value
- Report date
- 20 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Julianne Bruno in CRISPR Therapeutics AG
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.